MAPT and tauopathy: While multiple studies have suggested that LRRK2 mutations are not independently associated with primary tauopathies such as progressive supranuclear palsy or corticobasal degeneration [13, 14], Alzheimer’s disease-type tau pathology still appears consistently with LRRK2- and idiopathic PD [11].